- Home
- UNTY vs LYEL Comparison
UNTY vs LYEL Comparison
Compare UNTY & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UNTY | LYEL |
|---|---|---|
| Founded | 1991 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 497.6M | 490.1M |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | UNTY | LYEL |
|---|---|---|
| Price | $53.67 | $21.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $65.00 | $27.25 |
| AVG Volume (30 Days) | 33.2K | ★ 83.5K |
| Earning Date | 04-07-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.12% | N/A |
| EPS Growth | ★ 39.66 | N/A |
| EPS | ★ 5.67 | N/A |
| Revenue | N/A | ★ $36,000.00 |
| Revenue This Year | $11.57 | N/A |
| Revenue Next Year | $8.52 | $17,438.13 |
| P/E Ratio | $9.45 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $38.02 | $0.39 |
| 52 Week High | $57.30 | $45.00 |
Technical Indicators
Market Signals| Indicator | UNTY | LYEL |
|---|---|---|
| Relative Strength Index (RSI) | 66.79 | 53.15 |
| Support Level | $49.00 | $21.27 |
| Resistance Level | $56.98 | $27.30 |
| Average True Range (ATR) | 1.30 | 1.74 |
| MACD | 0.51 | 0.31 |
| Stochastic Oscillator | 96.55 | 88.58 |
Price Performance
Historical ComparisonAbout UNTY Unity Bancorp Inc.
Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. The Company has elected to become a financial holding company pursuant to regulations of the Board of Governors of the Federal Reserve System (the FRB). The Company's primary business is ownership and supervision of the Bank. The Company and the Bank derive a majority of their revenue from net interest income (i.e., the difference between the interest received on loans and securities and the interest paid on deposits and borrowings). The Company, through the Bank, conducts a traditional and community-oriented commercial banking business and services, personal and business checking accounts, time deposits, money market accounts, savings accounts, credit cards, automated teller service, and others.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.